Celebrating 13 Years of Nonprofit Independence
Menu
Shedding Light on the Risks
& Benefits of Medications 
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Menu
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
See topics

Autism

See topics
RECOMMENDED:
FDA SIDE EFFECTS UPDATE: Brain Infection Warning for Xeljanz, Neurological Risks for Tepezza, Plus More
FDA SIDE EFFECTS UPDATE: Brain Infection Warning for Xeljanz, Neurological Risks for Tepezza, Plus More
FDA SIDE EFFECTS UPDATE: New Allergic Reaction Warnings for Osteoporosis and Hypoparathyroidism Drugs
FDA SIDE EFFECTS UPDATE: New Allergic Reaction Warnings for Osteoporosis and Hypoparathyroidism Drugs
FDA SIDE EFFECTS UPDATE: Stelara and Alpha-Gal Allergy; Seizure Medication Linked to Severe Skin Reactions
FDA SIDE EFFECTS UPDATE: Stelara and Alpha-Gal Allergy; Seizure Medication Linked to Severe Skin Reactions

What is unbiased drug-safety journalism worth to you?

We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.

Donate to MedShadow
trigger

What is Unbiased Drug-Safety Journalism Worth to You?

We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.

As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.

trigger